Crestbridge has appointed Cheryl Bai as Director, Head of Funds UK. Bai has significant experience supporting complex fund structures across asset classes and domiciles and has worked with some of the largest fund management names in the UK and United States. Her experience also includes client relationship management, building service teams capable of high-quality delivery and specialist expertise in both financial and investor reporting. In her new role, Bai will lead the UK Funds team and contribute to the evolution and growth of Crestbridge’s UK private equity and real estate fund services proposition. Cheryl will help continue to drive Crestbridge’s

Parkwalk, the UK’s most active investor in technologies from UK universities and research institutions, has made three new hires following another successful year as investors recognise the opportunity in knowledge intensive start-ups.  

Alternative investment platform CAIS has appointed George Davies, PhD, as its new Head of Data. Based in the Company’s New York office, Davies will report to Shane Williams, Chief Technology Officer. “We are delighted to welcome George to this newly created position,” says Williams. “George’s track record working with data to enhance areas such as risk management, trade modelling, and pricing will complement our efforts to employ CAIS’ own data for trend spotting, creating personalised experiences for advisors, delivering meaningful engagements for managers, and informing business decisions.” Davies has worked with technology platforms across wealth advisory, asset management, and trading

MCF Corporate Finance, a corporate finance advisory firm, has appointed Atul Monga, CFA, as Partner in their technology practice in London. MCF specialises in cross-border and domestic M&A transactions and capitalraisings in Europe, across five core verticals: Business Services, Industrials, Consumer, Materials and Technology. The firm’s c60 professionals operate across offices in London, Helsinki, Stockholm, and Hamburg.   Since its establishment, the firm has advised on over 500 transactions, across multiple industry sectors and countries. The team continue to work in close partnership with DA Davidson, the growing North American investment bank.   Atul joins MCF’s growing technology team having

One Rock Capital Partners (One Rock) has added Adam Kuritzky to its team of Operating Partners. Kuritzky brings over 15 years of leadership and executive consulting experience in scaling and enhancing the sales and marketing functions for public and privately owned companies.  Working alongside One Rock Operating Partners Brian Potts and Kush Tulsidas, he will be responsible for assessing sales and marketing strategies at target companies and One Rock’s portfolio companies, post-acquisition.   Prior to being engaged by One Rock, Kuritzky served as a Vice President of Sales and then as an Executive Vice President of Sales and Marketing in

Jersey based fund administrator Saltgate Group has promoted Ajay Golam to its director group. Golam, based in the company’s London office, joined Saltgate in May 2016 as a manager and before his promotion was an Associate Director, Fund Accounting. In his new role, he will oversee the quality, accuracy, and efficiency of the accounting services provided to our clients. Julian Withrington, Saltgate’s Head of London, says: “Ajay embraces Saltgate’s values of engagement, commitment, integrity, and partnership every day . His presence will further strengthen our director group – Saltgate’s leaders of the future. “Ajay works hard to make sure our

Mishcon de Reya is expanding its offering to investors to cover a diverse range of investment strategies and markets, with the appointment of Angeli Arora. Arora’s former roles include regional leader of Private Equity (Africa) at Dentons and corporate partner at Akin Gump (including establishing their Hong Kong office to support key fund clients).   Arora advises on a wide range of investment strategies around the world, including Asia and Africa, where she spent several years. Angeli’s practice spans the investment spectrum – from special situations transactions, including activist/litigation strategies (a natural expansion of Mishcon’s market-leading litigation practice), to working

Fidelity International (Fidelity) has appointed Nick Haaijman as Global Head of Private Asset Solutions.  In this newly created role, Haaijman will be responsible for the development of Fidelity’s Private Assets Solutions capabilities globally. He will work closely with all of Fidelity’s Private Assets investment teams to develop and deliver best in class investment solutions that meet our clients’ ever evolving needs. Haaijman joins from CVC Credit Partners where he held the position of Head of Client Servicing. In the role, he led the project management process for global fundraisings across credit funds, both illiquid and liquid. Prior to joining CVC

Cyber and advanced technologies investor Paladin Capital Group is pleased to announce that Najwa Aaraj has been appointed to the firm’s Strategic Advisory Group.  With 20 years’ academic and commercial experience in deeptech research and development, Aaraj will help Paladin to assess investments in cybersecurity, cryptographic and quantum technologies, and support Paladin’s portfolio companies in realising their growth plans. Aaraj is Chief Researcher, Cryptography Research Center and Acting Chief Researcher, Autonomous and Robotics Research Center, for the UAE’s Technology Innovation Institute (TII). The Cryptography Research Center focuses on research and development in cryptography, cloud confidential computing, and machine learning for

Coave Therapeutics (Coave), a clinical-stage biotechnology company backed by international life science and strategic investors Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures, Kurma Partners, Idinvest, GO Capital, Sham Innovation Santé/Turenne, has strengthened its leadership team with the appointments of Thomas Blaettler MD, as Chief Medical Officer, and Patricia Françon PhD, to the newly created position of Chief Operating Officer. “I am very pleased to welcome Thomas and Patricia to the leadership team at Coave. Their collective accomplishments and deep domain expertise in neuroscience, cell and gene therapy, in addition to their extensive clinical drug development